Back to search

The clinical evaluation of analogues

Data up to Jan 2025

Published1978
Citations36
References18

Total Citations Per Year

Abstract

References (18)

A clinical review of bleomycin—a new antineoplastic agent

1973 • 860 citations

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

1975 • 749 citations

Bleomycin, an Antitumor Antibiotic

1972 • 293 citations

Toxicity of Antineoplastic Agents in Man: Chromosomal Aberrations, Antifertility Effects, Congenital Malformations, and Carcinogenic Potential

1976 • 276 citations

Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy.

1976 • 154 citations

Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.

1975 • 132 citations

The integration of chemotherapy into a combined modality approach to cancer therapy

1975 • 103 citations

Integration of chemotherapy into combined modality treatment of solid tumors

1974 • 73 citations

COMB (cyclophosphamide, oncovin, methyl-ccnu, and bleomycin): A four-drug combination in solid tumors

1975 • 64 citations

Effects of bleomycin on pulmonary function in man.

1973 • 56 citations

Clinical trials in cancer chemotherapy

1977 • 49 citations

Chemotherapy of non-Hodgkin's lymphomas

1974 • 30 citations

Cancer Treatment Today and Its Impact on Drug Development, With Special Emphasis on the Phase II Clinical Trial

1976 • 30 citations

Results of combination chemotherapy of non-Hodgkin's lymphoma.

1975 • 18 citations

Cancer chemotherapy as it approaches middle age

1978 • 11 citations

Current status of American studies with bleomycin.

1976 • 8 citations

Studies on the Clinical Pharmacology of Bleomycin

1978 • 7 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
The clinical evaluation of analogues (1978) – Cancer Chemotherapy and Pharmacology | Metascience Observatory Explorer